Engineered T cells and their therapeutic applications in autoimmune diseases

被引:13
|
作者
Bao, Lei [1 ]
Bo, Xiao-Chen [1 ]
Cao, Huai-Wen [1 ]
Qian, Chen [1 ]
Wang, Zeng [1 ]
Li, Bin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Dept Immunol & Microbiol, Shanghai 200025, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Chimeric antigen receptor T cells; Cell immunotherapy; Autoimmune diseases; SYSTEMIC-LUPUS-ERYTHEMATOSUS; B-CELL; RHEUMATOID-ARTHRITIS; PEMPHIGUS-VULGARIS; CD19; CAR; CLINICAL DEVELOPMENT; MICROSCOPIC COLITIS; GENE-TRANSFER; IN-VITRO; ANTIGEN;
D O I
10.24272/j.issn.2095-8137.2021.363
中图分类号
Q95 [动物学];
学科分类号
071002 ;
摘要
Chimeric antigen receptor T cells (CAR-T cells) are engineered recombinant T cells, which were initially used to treat hematopoietic malignancies and are now widely used in the treatment of various diseases. Considering their intrinsic targeting efficiency, CAR-T cells show considerable potential in the treatment of autoimmune diseases. Furthermore, regulatory T cells (Treg), a subset of CD4 T cells exhibiting immunosuppressive functions, have attracted increasing attention regarding CAR-Treg cell production. In this review, we report on recent developments in preclinical and clinical studies on CAR-T cells in autoimmune diseases and provide an outlook on opportunities and challenges of CAR-T application in such diseases.
引用
收藏
页码:150 / 165
页数:16
相关论文
共 50 条
  • [31] T follicular helper cells and T follicular regulatory cells in autoimmune diseases
    Qi, Jingjing
    Liu, Chang
    Bai, Ziran
    Li, Xia
    Yao, Genhong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [32] Regulatory T cells in autoimmune diseases: Anti-ergotypic T cells
    Mimran, A
    Cohen, IR
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2005, 24 (3-4) : 159 - 179
  • [33] Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases
    DelaRosa, Olga
    Dalemans, Wilfried
    Lombardo, Eleuterio
    CURRENT OPINION IN BIOTECHNOLOGY, 2012, 23 (06) : 978 - 983
  • [34] Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases
    Ben-Ami, Eyal
    Berrih-Aknin, Sonia
    Miller, Ariel
    AUTOIMMUNITY REVIEWS, 2011, 10 (07) : 410 - 415
  • [35] Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction
    Gharagozloo, Marjan
    Majewski, Slawomir
    Foldvari, Marianna
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (04) : 1003 - 1018
  • [36] Therapeutic Potential of Regulatory T cells in Autoimmune Disorders
    Fessler, Johannes
    Felber, Anja
    Duftner, Christina
    Dejaco, Christian
    BIODRUGS, 2013, 27 (04) : 281 - 291
  • [37] Therapeutic Potential of Regulatory T cells in Autoimmune Disorders
    Johannes Fessler
    Anja Felber
    Christina Duftner
    Christian Dejaco
    BioDrugs, 2013, 27 : 281 - 291
  • [38] Shifting gears with CAR T cells for autoimmune diseases
    Kale, Brandon
    Khosravi-Maharlooei, Mohsen
    Perna, Fabiana
    MOLECULAR THERAPY, 2024, 32 (02) : 261 - 263
  • [39] THE ROLE OF T-CELLS IN AUTOIMMUNE-DISEASES
    COOKE, A
    LYDYARD, PM
    PATHOLOGY RESEARCH AND PRACTICE, 1981, 171 (02) : 173 - 196
  • [40] Advances in the role of helper T cells in autoimmune diseases
    Zhang, Xiao-Mei
    Liu, Chun-Yan
    Shao, Zong-Hong
    CHINESE MEDICAL JOURNAL, 2020, 133 (08) : 968 - 974